PRGO - Total Utang marang Modal Perrigo Corp

Logo perusahaan publik Perrigo Company plc (PRGO)

Perrigo Company plc (PRGO) relies on the production of private-label products for pharmacies, which provides the company with defensive qualities during economic downturns. However, fierce competition in the generics segment and regulatory inspections create certain challenges. The leverage ratio is 1.36. The price action of the over-the-counter manufacturer, which attracts industry experts and develops an internal talent pool, is presented in the chart below.

PRGO: Total Utang marang Modal Perrigo 04.07.2022 - 29.10.2026
Barang utama Perrigo Corp

Investors assess the margin of safety for Perrigo Company plc (PRGO) via the total liabilities-to-equity ratio to determine the business's degree of dependence on external financing. Stable demand for over-the-counter drugs allows Perrigo Company plc (PRGO) to optimize this leverage metric on GURU.Markets, transforming borrowed resources into a tool for scaling production while maintaining its status as a reliable asset.

Analisis pesaing Perrigo Company plc

Utang marang Ekuitas Haleon|Kenvue Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal VRNA|MENS (Jyong Bio) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|Total Utang marang Modal amneal.com AMRX|ALVO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi LQDA (Liquidia Corp)|Galapagos Genomics (GLPG) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas ANI Pharmaceuticals Corp|MNKD (MannKind Corporation) - Total Utang marang Modal|Total Utang marang Modal amphastar.com|Rasio Total Utang marang Ekuitas PCRX (Pacira BioSciences, Inc.)|SPRY (ARS Pharmaceuticals Inc) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Theravance TBPH|Aquestive Corp (AQST) - Utang marang Modal|SCPH: Rasio Total Utang marang Ekuitas|Tectonic Therapeutic, Inc. - Utang Agregat marang Modal|TNXP: Total Utang marang Modal|China SXT Pharmaceuticals, Inc. - Rasio Kabeh Utang marang Dana Pribadi|EPRX (Eupraxia Pharmaceuticals, Inc.) - Total Utang marang Modal|Utang marang Modal BioHarvest Sciences Inc BHST|Utang marang Ekuitas eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Entera Bio ENTX|HYFT (MindWalk Holdings, Inc.) - Utang Agregat marang Ekuitas|ABVC BioPharma Inc - Total Utang marang Modal|Utang marang Modal Cumberland Corp|Quantum BioPharma Ltd (QNTM) - Utang marang Ekuitas|fibrogen.com - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Telomir Pharmaceuticals, Inc.|RANI: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SNYR|Koefisien Total Utang marang Modal rallybio.com|Total Utang marang Modal LEXX (Lexaria Bioscience Corp.)|Rasio Utang marang Modal pulmatrix.com|PTHL - Utang marang Ekuitas|Utang marang Modal Aptorum Group Limited|LYRA (Lyra Therapeutics, Inc) - Rasio Total Utang marang Ekuitas|Impact BioMedical, Inc. - Rasio Kabeh Utang marang Dana Pribadi|TNFA (TNF Pharmaceuticals Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas cbdMD Corp (YCBD)|Utang marang Ekuitas PainReform (PRFX)|CYTO - Utang marang Modal|Utang marang Ekuitas Lipella LIPO|OPTN - Rasio Total Utang marang Ekuitas|PIRS - Utang marang Ekuitas|Utang Agregat marang Ekuitas PROC|PTPI: Total Utang marang Modal|Qilian International Holding Group (QLI) - Total Utang marang Modal|Utang marang Ekuitas ACELYRIN, Inc.|Rasio Utang marang Ekuitas TFFP (TFF Pharmaceuticals, Inc)